|
|
Article: p53 gene abnormality restricted to poorly differentiated endocrine carcinomas.
- Article from:
- Clinical Oncology Week
- Article date:
- May 24, 2004
CopyrightCOPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2004 MAY 24 - (NewsRx.com & NewsRx.net) -- p53 gene abnormality is restricted to poorly differentiated endocrine carcinomas.
According to a recent report from Italy, "Endocrine turnouts of gut and pancreas tract are rare entities originating from cells of the diffuse endocrine system. The endocrine phenotype is assessed by the expression of general and specific endocrine markers.
"General endocrine markers associate to organelles like large dense core vesicles (e.g., chromogranin A) and small synaptic-like vesicles (e.g. synaptophysin), or to the cytosol, like neuron specific enolase and protein gene product 9.5 (PGP9.5). The specific markers correspond ...